EUA for bamlanivimab revoked April 16 2021 FDA letter press release fact sheet

Submitted by vgreene on Thu, 06/03/2021 - 19:06
Detail (Long)
EUA for bamlanivimab revoked April 16, 2021: <a href=https://www.fda.gov/media/147629/download?utm_medium=email&utm_source=govdelivery><b><u>FDA letter</u></b></a>, <a href=https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-monoclonal-antibody-bamlanivimab><b><u>press release</u></b></a>, <a href=https://www.fda.gov/media/143603/download><b><u>fact sheet</u></b></a>